Phillip Scheinberg, M.D. | Aplastic Anemia and MDS International Foundation

Phillip Scheinberg, M.D.

Dr. Phillip Scheinberg is a staff clinician at the Hematology Branch of the National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH) in Bethesda, MD. He is currently involved in clinical protocols in bone marrow failure syndromes such as aplastic anemia, myelodysplastic syndromes and large granular lymphocytic leukemia. The focus of these protocols is to investigate novel immunosuppressive regimens that will improve the response rate in untreated severe aplastic anemia (SAA) and prevent relapses and clonal evolution to myelodysplastic syndromes. In patients with SAA who are not responsive to initial anti-thymocyte globulin (ATG) and cyclosporine, protocols are being developed to improve the success of salvage therapies with repeat immunosuppressive therapy. Dr. Scheinberg received an MD Degree in 1995 in Sao Paulo, Brazil, completed an internship and residency (1997-2001) at Mount Sinai Medical Center in Miami Beach, FL and a Hematology/Oncology Fellowship (2001-2005) at the Hematology Branch of NHLBI